Kane Biotech, Inc. (KNE.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Kane Biotech Max Drawdown (5Y) : 86.96% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 86.96% |
| June 30, 2026 | 86.96% |
| May 31, 2026 | 86.96% |
| April 30, 2026 | 86.96% |
| March 31, 2026 | 86.96% |
| February 28, 2026 | 86.96% |
| January 31, 2026 | 86.96% |
| December 31, 2025 | 86.96% |
| November 30, 2025 | 86.96% |
| October 31, 2025 | 86.96% |
| September 30, 2025 | 84.78% |
| August 31, 2025 | 84.78% |
| July 31, 2025 | 82.61% |
| June 30, 2025 | 80.43% |
| May 31, 2025 | 78.26% |
| April 30, 2025 | 78.26% |
| March 31, 2025 | 78.26% |
| February 28, 2025 | 78.26% |
| January 31, 2025 | 78.26% |
| December 31, 2024 | 78.26% |
| November 30, 2024 | 78.26% |
| October 31, 2024 | 78.26% |
| September 30, 2024 | 78.26% |
| August 31, 2024 | 78.26% |
| July 31, 2024 | 78.26% |
| Date | Value |
|---|---|
| June 30, 2024 | 78.26% |
| May 31, 2024 | 78.95% |
| April 30, 2024 | 85.71% |
| March 31, 2024 | 86.67% |
| February 29, 2024 | 86.67% |
| January 31, 2024 | 86.67% |
| December 31, 2023 | 87.50% |
| November 30, 2023 | 88.33% |
| October 31, 2023 | 88.33% |
| September 30, 2023 | 90.00% |
| August 31, 2023 | 90.00% |
| July 31, 2023 | 90.00% |
| June 30, 2023 | 90.40% |
| May 31, 2023 | 90.40% |
| April 30, 2023 | 90.40% |
| March 31, 2023 | 90.40% |
| February 28, 2023 | 90.40% |
| January 31, 2023 | 90.40% |
| December 31, 2022 | 90.40% |
| November 30, 2022 | 90.40% |
| October 31, 2022 | 90.40% |
| September 30, 2022 | 90.40% |
| August 31, 2022 | 90.40% |
| July 31, 2022 | 90.40% |
| June 30, 2022 | 90.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Quest PharmaTech, Inc. | 94.00% |
| BriaCell Therapeutics Corp. | -- |
| Vaxil Bio Ltd. | 99.63% |
| Waverley Pharma, Inc. | 96.77% |
| Goldcoast Resource Corp. | 99.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -38.50 |
| Beta (5Y) | 0.2688 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 49.03% |
| Historical Sharpe Ratio (5Y) | -0.7241 |
| Historical Sortino (5Y) | -1.193 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.05% |